Abstract P5-11-04: Therapy-induced priming of natural killer cells predicts patient-specific tumor rejection in multiple breast cancer indications

MLA

Hans Gertje, et al. “Abstract P5-11-04: Therapy-Induced Priming of Natural Killer Cells Predicts Patient-Specific Tumor Rejection in Multiple Breast Cancer Indications.” Cancer Research, vol. 78, Feb. 2018, pp. P5-11. EBSCOhost, https://doi.org/10.1158/1538-7445.sabcs17-p5-11-04.

APA

Hans Gertje, Padhma Radhakrishnan, Aaron Goldman, L Maciejko, Manjusha Biswas, Saravanan Thiyagarajan, Mark Lawson, Gb K, Allen Thayakumar, Biswanath Majumder, Baraneedharan Ulaganathan, Munisha Smalley, Basavaraja U. Shanthappa, & Kodaganur S. Gopinath. (2018). Abstract P5-11-04: Therapy-induced priming of natural killer cells predicts patient-specific tumor rejection in multiple breast cancer indications. Cancer Research, 78, P5-11. https://doi.org/10.1158/1538-7445.sabcs17-p5-11-04

Chicago

Hans Gertje, Padhma Radhakrishnan, Aaron Goldman, L Maciejko, Manjusha Biswas, Saravanan Thiyagarajan, Mark Lawson, et al. 2018. “Abstract P5-11-04: Therapy-Induced Priming of Natural Killer Cells Predicts Patient-Specific Tumor Rejection in Multiple Breast Cancer Indications.” Cancer Research 78 (February): P5-11. doi:10.1158/1538-7445.sabcs17-p5-11-04.